ap26238705740891

FDA approves new pancreatic cancer drug that could extend patients’ lives

The Food and Drug Administration on Wednesday approved a groundbreaking new drug for advanced pancreatic cancer, offering U.S. patients a more effective treatment against one of the deadliest types of cancer. FDA officials gave expedited approval to the first-of-a-kind pill, called daraxonrasib, which blocks a mutated protein that fuels tumor growth in more than 90%…

Read More
gettyimages 2289380329

Trump and Kennedy’s health industry deals haven’t been enforced and are at risk of vanishing

In the thick of his competitive reelection race in Michigan, Republican Rep. Tom Barrett joined Health and Human Services Secretary Robert F. Kennedy Jr. at a sprawling 400-acre apple orchard, farm, and winery. They touted Trump administration efforts to improve the American diet, including the removal of some artificial dyes from processed foods. “We had…

Read More
270012437920e3e.webp

Nationwide deaths this monsoon cross 100; more rain likely in country’s upper parts from July 29 – Pakistan

As monsoon showers continued to hit parts of the country, the National Disaster Management Authority (NDMA) on Sunday reported seven more casualties in Punjab and three in Khyber Pakhtunkhwa, taking the countrywide death toll since June 26 to above 100. According to an NDMA daily situation report covering 24 hours up till 1pm, Punjab’s Gujrat…

Read More
26141134385bc8a.webp

Chenab flood level eases from medium to low; PMD forecasts more rain in upper parts of Punjab from July 29 – Pakistan

Chenab continued to witness flooding on Sunday, but with flow eased from medium to low, as the Met Office forecast a fresh rainfall spell from July 29 in the upper catchments of all major rivers, as well as Islamabad, upper Punjab and northern parts of the country. The Provincial Disaster Management Authority (PDMA) in Punjab…

Read More
cbsn fusion what to know about medicare covering glp 1 drugs thumbnail

Novo Nordisk sues Eli Lilly over “maliciously and deceptively false” GLP-1 ads

Novo Nordisk sued competitor Eli Lilly on Tuesday, alleging the drugmaker engaged in false advertising by claiming its GLP-1 drugs are superior to Novo’s. The lawsuit accuses Eli Lilly of misleading consumers by using outdated clinical trial data to make Zepbound and Mounjaro appear more effective than Novo’s drugs, Wegovy and Ozempic, for weight loss…

Read More